This Department of Defense grant supports collaborative research and clinical trials to facilitate the development and approval of vaccines, devices, and drugs for the warfighter. The goal is to conduct trials and epidemiologic studies to meet FDA approval, ultimately enhancing medical readiness for the military. Closing date: Nov 08, 2019.
Opportunity ID: 321453
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | N62645-PA-20-01 |
| Funding Opportunity Title: | Conduct of Clinical Trials to Facilitate the Development and Approval of Novel Countermeasures (vaccines, devices, drugs) for Use by the Warfighter |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 12.340 — Naval Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 09, 2019 |
| Last Updated Date: | Oct 09, 2019 |
| Original Closing Date for Applications: | Nov 08, 2019 |
| Current Closing Date for Applications: | Nov 08, 2019 |
| Archive Date: | Dec 08, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $41,822,342 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | NAVAL MEDICAL LOGISTICS COMMAND |
| Description: |
The goal of this Cooperative Agreement is to engage in a collaborative research and development (R&D) effort to support the research mission of NAMRU-6. The collaborative R&D effort will include conducting clinical trials, and epidemiologic studies in support of clinical trials, so products can be approved/cleared by the U.S. Food and Drug Administration (FDA) for use by the warfighter. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jaclyn Svincek
Grantor Phone 301-619-8433 Email:jaclyn.p.svincek.civ@mail.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 321453 Full Announcement-Program Ann. and App. Inst -> N62645-PA-20-1- Application Instructions.pdf
Folder 321453 Full Announcement-Program Ann. and App. Inst -> N62645-PA-20-1 – Program Announcement.pdf
Folder 321453 Full Announcement-Program Ann. and App. Inst -> Question and Answer N62645-PA-20-1 Draft FINAL.pdf
Packages
| Agency Contact Information: | Jaclyn Svincek Grantor Phone 301-619-8433 Email: jaclyn.p.svincek.civ@mail.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.340 | PKG00255717 | Oct 09, 2019 | Nov 08, 2019 | View |
Package 1
Mandatory forms
321453 RR_SF424_2_0-2.0.pdf
321453 RR_Budget_1_4-1.4.pdf
321453 AttachmentForm_1_2-1.2.pdf
321453 RR_KeyPersonExpanded_2_0-2.0.pdf
321453 RR_PersonalData_1_2-1.2.pdf
Optional forms
321453 RR_SubawardBudget_1_4-1.4.pdf
321453 SFLLL_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
